Ophthalmology specialist Iveric snapped up by Astellas for $5.9 billion

The Japanese pharmaceutical giant Astellas Pharma has taken over the U.S. company Iveric Bio in a $5.9 billion deal to get hold of its ophthalmology-focused pipeline.

Related Keywords

Iveric Bio ,Apellis Pharma Syfovre ,Pravinu Dugel ,Drug Administration ,Astellas Us Holding ,Berry Merger Sub ,Apellis Pharma ,